Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
32%
OVERLAP
BY WEIGHT
18
# OF OVERLAPPING
HOLDINGS
FBT
31
HOLDINGS
60%
ALSO IN BBP
BBP
65
HOLDINGS
30%
ALSO IN FBT
SECTOR DRIFT (FBT minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBT |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 4.7% | 3.0% | 3.0% |
|
BEIGENE LTD. SPONSORED ADR | 4.1% | 2.9% | 2.9% |
|
HALOZYME THERAPEUTICS INC | 4.3% | 2.6% | 2.6% |
|
ACADIA PHARMACEUTICALS INC | 3.6% | 2.4% | 2.4% |
|
GILEAD SCIENCES INC | 3.3% | 2.1% | 2.1% |
FBT Overweight Relative to BBP
 |
ARGENX SE ADR | 4.3% |
 |
GENMAB A/S SPONSORED ADR | 4.2% |
|
VERACYTE INC | 3.6% |
|
NATERA INC | 3.4% |
|
EXACT SCIENCES CORP | 3.3% |
 |
METTLER-TOLEDO INTERNATIONAL | 3.3% |
|
CORCEPT THERAPEUTICS INC | 3.2% |
|
ILLUMINA INC | 3.1% |
 |
ALKERMES PLC | 2.8% |
|
SAREPTA THERAPEUTICS INC | 2.8% |
FBT Underweight Relative to BBP
|
INSMED INC | -3.3% |
|
BRIDGEBIO PHARMA, INC. | -3.2% |
|
RHYTHM PHARMACEUTICALS, INC. | -3.0% |
|
MIRUM PHARMACEUTICALS, INC. | -3.0% |
|
IONIS PHARMACEUTICALS, INC. | -2.7% |
|
INTRA-CELLULAR THERAPIES INC | -2.6% |
|
ASCENDIS PHARMA A/S | -2.6% |
|
PHATHOM PHARMACEUTICALS, INC. | -2.5% |
|
SAGE THERAPEUTICS INC | -2.5% |
|
LIGAND PHARMACEUTICALS-CL B | -2.4% |